Hughes Eric A

Executive VP Global R&D and Chief Med Officer at TEVA

Sold, on record
$7.5M
Dollars the filings state
Form 4 sales
11
Latest Aug 3, 2026
Form 144 notices
9
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TEVATEVA PHARMACEUTICAL INDUSTRIES LTDExecutive VP Global R&D and Chief Med Officer

Sales by reason

9
Routine
0
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice TEVANotice
    Mar 3, 2026 2026

    Filed to sell 80,762 shares ($2.6M)

    Hughes Eric A, Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

    10b5-1 plan3.3x usual sizeFiling

  2. 2 Form 4 sale TEVAUnusual
    Mar 3, 2026 same day

    Sold 80,762 shares at $32.36 ($2.6M)

    Hughes Eric A, "See ""Remarks"""

    10b5-1 planSold 48.5% of holdings ($5.4M position)85,616 shares left3.3x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice TEVANotice
    Mar 4, 2026 +1 day

    Filed to sell 11,277 shares ($366k)

    Hughes Eric A, Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

    10b5-1 plan0.5x usual sizeFiling

  4. 4 Form 4 sale TEVARoutine
    Mar 4, 2026 same day

    Sold 11,277 shares at $32.46 ($366k)

    Hughes Eric A, "See ""Remarks"""

    10b5-1 planSold 10.4% of holdings ($3.5M position)97,590 shares left0.5x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice TEVANotice
    Mar 5, 2026 +1 day

    Filed to sell 9,533 shares ($302k)

    Hughes Eric A, Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER

    10b5-1 plan0.4x usual sizeFiling

  6. 6 Form 4 sale TEVARoutine
    Mar 5, 2026 same day

    Sold 9,533 shares at $31.67 ($302k)

    Hughes Eric A, "See ""Remarks"""

    10b5-1 planSold 8.1% of holdings ($3.7M position)107,711 shares left0.4x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice TEVANotice
    Aug 3, 2026 +151 days

    Filed to sell 25,578 shares ($892k)

    Hughes Eric A, Executive VP Global R&D and Chief Med Officer

    10b5-1 plan1x usual sizeFiling

  8. 8 Form 4 sale TEVARoutine
    Aug 3, 2026 same day

    Sold 25,578 shares at $34.88 ($892k)

    Hughes Eric A, "See ""Remarks"""

    10b5-1 planSold 15.9% of holdings ($5.6M position)134,877 shares left1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Hughes Eric A
Source
Aug 3, 2026Aug 5, 2026TEVA"See ""Remarks"""Form 4 sale25,578$892k15.9%RoutineSEC
Aug 3, 2026Aug 3, 2026TEVAExecutive VP Global R&D and Chief Med OfficerForm 144 notice25,578$892kNoticeSEC
Mar 5, 2026Mar 9, 2026TEVA"See ""Remarks"""Form 4 sale9,533$302k8.1%RoutineSEC
Mar 5, 2026Mar 5, 2026TEVAOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICERForm 144 notice9,533$302kNoticeSEC
Mar 4, 2026Mar 6, 2026TEVA"See ""Remarks"""Form 4 sale11,277$366k10.4%RoutineSEC
Mar 4, 2026Mar 4, 2026TEVAOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICERForm 144 notice11,277$366kNoticeSEC
Mar 3, 2026Mar 5, 2026TEVA"See ""Remarks"""Form 4 sale80,762$2.6M48.5%UnusualSEC
Mar 3, 2026Mar 3, 2026TEVAOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICERForm 144 notice80,762$2.6MNoticeSEC
Aug 1, 2025Aug 5, 2025TEVA"See ""Remarks"""Form 4 sale52,742$800k100.0%RoutineSEC
Aug 1, 2025Aug 1, 2025TEVAOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICERForm 144 notice52,742$799kNoticeSEC
Mar 5, 2025Mar 6, 2025TEVA"See ""Remarks"""Form 4 sale23,251$367k100.0%RoutineSEC
Mar 4, 2025Mar 5, 2025TEVA"See ""Remarks"""Form 4 sale24,900$400k100.0%RoutineSEC
Mar 4, 2025Mar 4, 2025TEVAOfficer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICERForm 144 notice23,251$372kNoticeSEC
Mar 3, 2025Mar 3, 2025TEVAOfficer, EXECUTIVE VP GLOBAL R & D CHIEF MEDICAL OFFICERForm 144 notice24,900$410kNoticeSEC
Aug 12, 2024Aug 12, 2024TEVAOfficer, EXECUTIVE VP GLBL R AND D AND CHIEF MED OFFForm 144 notice45,060$783kNoticeSEC
Aug 9, 2024Aug 13, 2024TEVA"See ""Remarks"""Form 4 sale45,060$783k100.0%UnusualSEC
Aug 1, 2024Aug 5, 2024TEVA"See ""Remarks"""Form 4 sale24,537$423k35.3%RoutineSEC
Aug 1, 2024Aug 1, 2024TEVAOfficer, EXECUTIVE VP GLBL R AND D AND CHIEF MED OFFForm 144 notice24,537$423kNoticeSEC
Mar 4, 2024Mar 5, 2024TEVA"See ""Remarks"""Form 4 sale8,045$107k32.3%RoutineSEC
Aug 1, 2023Aug 3, 2023TEVA"See ""Remarks"""Form 4 sale52,742$438k100.0%RoutineSEC